Unknown PHASE3 INTERVENTIONAL 2-arm NCT01226225

A Multicentre Trial on the Effectiveness of Physical Rehabilitation of Patients With Coronary Artery Disease: Aerobic Interval Training Versus Moderate Continuous Training. (SAINTEX-CAD)

Sponsor: KU Leuven

Conditions Coronary Artery Bypass Grafting (CABG) Coronary Artery Disease (CAD); Myocardial Infarction (MI) Percutaneous Coronary Intervention (PCI)

Interventions Aerobic interval training Moderate endurance training

Updated 7 times since 2017 Last updated: Nov 9, 2010 Started: Nov 30, 2010 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01226225, this PHASE3 trial focuses on Coronary Artery Bypass Grafting (CABG) and Coronary Artery Disease (CAD); and remains ongoing. Sponsored by KU Leuven, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2021 — Nov 2022 [monthly]

Unknown Status PHASE3
Aug 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 2 earlier versions

Jun 2018 — Aug 2018 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KU Leuven
Universitaire Ziekenhuizen KU Leuven
University Hospital, Antwerp

Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edegem, Belgium
• Leuven, Belgium